Inactive Instrument
Taiwan Liposome Company, Ltd. Stock Nasdaq
Stocks
TLC
US8740381020
Biotechnology & Medical Research
| Manager | Title | Age | Since |
|---|---|---|---|
Chih Hung Yeh
CEO | Chief Executive Officer | 54 | - |
Amanda Sung
DFI | Director of Finance/CFO | - | 2024-04-30 |
| Chief Tech/Sci/R&D Officer | 79 | 2019-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kee Lung Hong
CHM | Chairman | 83 | 2003-06-26 |
Chan Yue Li
BRD | Director/Board Member | 54 | 2014-06-17 |
Chih Hung Yeh
BRD | Director/Board Member | 54 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +1.03% | - | - | 299M | |
| -2.25% | +1.55% | +50.84% | +70.04% | 56.19B | |
| -1.32% | -2.71% | +34.27% | +77.57% | 54.83B | |
| +1.49% | +0.13% | -18.03% | -13.94% | 23.04B | |
| -0.57% | -4.13% | +2.34% | +387.73% | 22.7B | |
| +1.45% | +0.82% | +16.55% | -11.20% | 20.23B | |
| 0.00% | +3.00% | +27.41% | -29.52% | 17.83B | |
| -5.17% | -6.58% | +22.53% | +539.31% | 15.65B | |
| -6.69% | -5.11% | +169.13% | +304.89% | 15.24B | |
| +1.25% | +0.69% | +27.30% | +184.69% | 14.03B | |
| Average | -1.16% | -0.17% | +36.93% | +167.73% | 26.64B | |
| Weighted average by Cap. | -1.29% | -0.21% | +35.50% | +131.79% |
Employees
161
